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A B S T R A C T
Premature senescence, a death escaping pathway for cells experiencing stress, is conducive to aging and car-
diovascular diseases. The molecular switch between senescent and apoptotic fate remains, however, poorly
recognized. Nrf2 is an important transcription factor orchestrating adaptive response to cellular stress. Here, we
show that both human primary endothelial cells (ECs) and murine aortas lacking Nrf2 signaling are senescent
but unexpectedly do not encounter damaging oxidative stress. Instead, they exhibit markedly increased S-ni-
trosation of proteins. A functional role of S-nitrosation is protection of ECs from death by inhibition of NOX4-
mediated oxidative damage and redirection of ECs to premature senescence. S-nitrosation and senescence are
mediated by Keap1, a direct binding partner of Nrf2, which colocalizes and precipitates with nitric oxide syn-
thase (NOS) and transnitrosating protein GAPDH in ECs devoid of Nrf2. We conclude that the overabundance of
this “unrestrained” Keap1 determines the fate of ECs by regulation of S-nitrosation and propose that Keap1/
GAPDH/NOS complex may serve as an enzymatic machinery for S-nitrosation in mammalian cells.
1. Introduction
Cellular senescence is a state of permanent cell cycle arrest with
concomitantly maintained metabolic activity and viability. Senescence
may be caused by DNA damage, response to oncogene activation,
tumor-suppressor loss, or cellular stress. There is much evidence that
premature senescence contributes to aging and age-related diseases [1].
Such dependency also applies to the vascular system, manifesting as an
increased risk of cardiovascular disorders (CVDs) [2]. The endothelium
is particularly exposed to adverse signals, allowing it to undergo pre-
mature senescence and become dysfunctional, which facilitates the
onset of CVD [3].
Previous studies demonstrated that Nrf2, encoded by NFE2L2 (nu-
clear factor (erythroid-derived 2)-like 2) is one of the key players
maintaining a healthy endothelial phenotype [4–7]. Nrf2 is a tran-
scription factor mediating an adaptive response to cellular stress. A
number of genes encoding detoxifying enzymes (glutathione S-
transferase (GST), NAD(P)H:quinone oxidoreductase (NQO1)), stress-
responsive proteins (heme oxygenase-1 (HMOX1)), and enzymes re-
sponsible for the elimination of superoxide and hydroperoxides (glu-
tathione peroxidase (GPX), superoxide dismutase (SOD)), are directly
regulated by Nrf2. When Nrf2 escapes Keap1-mediated proteolysis, it
activates transcription of a large number of protective enzymes through
binding to the electrophile response element, EpRE (also known as the
antioxidant response element (ARE)) located in their promoters [8].
Not surprisingly, inhibition of Nrf2 activity was shown to make mice
susceptible to oxidative damage [9–12]. Changes in basal Nrf2 level
may decrease or increase with age [13–15], but more consistently, the
ability to activate Nrf2 above the basal level declines with age, which
may explain the ineﬀective Nrf2-dependent antioxidant defense in
vascular cells seen in the elderly [16]. Senescence-associated mechan-
isms for declining Nrf2 activity are, however, unclear. The molecular
mechanism of senescence driven by Nrf2 inhibition, especially in en-
dothelial cells (ECs), also remains unidentiﬁed. Furthermore, the
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factors that determine whether a cell undergoes senescence or apoptosis
are not established.
One of the key molecules modulating response and function of a
vascular system and ECs is nitric oxide (˙NO), which is produced in cells
by nitric oxide synthases (NOS). The classical pathway triggered by ˙NO
in blood vessels activates soluble guanyl cyclase, producing cGMP,
which results in vasodilatation of vascular smooth muscle cells (VSMCs)
and modulation of blood pressure [17]. Noteworthy, ˙NO can also in-
ﬂuence the cellular response through protein S-nitrosation (SNO) [18],
which is an oxidative chemical reaction that generates a nitroso group
on a thiol. The chemistry through which this reaction occurs in mam-
mals is still uncertain, though several non-enzymatic mechanisms have
been proposed so far [19]. In bacteria, an enzymatic complex of
NarGHI, Hcp and GAPDH, or NO synthase, SNO synthase and transni-
trosating protein, respectively, has recently been demonstrated to cat-
alyze SNO formation [20]. The SNO posttranslational modiﬁcation has
been shown in many proteins that are involved in the regulation of
apoptosis, migration, transport and cell division [21]. A ‘switch-oﬀ’
mechanism is a denitrosation, performed mainly by S-ni-
trosoglutathione reductase (GSNOR) and thioredoxin reductases
(TrxRs). Several proteins are constitutively nitrosated in the cell, and
denitrosation serves as a mechanism for their activation [22].
Recently we found that loss of Nrf2 transcription factor leads to the
induction of p53-dependent premature senescence in primary human
aortic endothelial cells (HAECs) [23]. The molecular mechanism that
triggers the onset of senescence when Nrf2 signaling is absent and its
relevance in vivo remains to be clariﬁed. In this paper, we demonstrate
that Keap1, unhampered by an interaction with Nrf2, is involved in
protein S-nitrosation in ECs that provides protection from NOX4-
mediated oxidative damage and apoptosis while redirecting them to
senescence. Moreover, we found that in Nrf2-deﬁcient cells, Keap1 in-
teracts with GAPDH and NOS, which may provide the machinery for S-
nitrosation similar to that seen in bacteria [20].
2. Materials and methods
Animals. Nrf2-transcriptional knockout (tKO) C57BL/6 J mice, in-
itially developed by Prof. Masayuki Yamamoto [24], were kindly pro-
vided by Prof. Antonio Cuadrado (Universidad Autonoma de Madrid)
together with WT mice. 8-week old male and female animals were used
in the study. In tKO animals, DNA binding domain of Nrf2 was replaced
by LacZ gene [24], which generates a fusion protein N-terminal Nrf2-β-
galactosidase [25,26]. As the previous paper shows, this protein can be
detected only in response to electrophilic response, but not in control
conditions [25]. To make sure that it is possible to distinguish its ac-
tivity from the senescence-related one, we performed additional ex-
periments on lung ﬁbroblast and aortas isolated from WT and tKO mice.
Importantly, the activity of β-gal of LacZ origin can be detected only at
pH 7 [27], while senescence-associated-β-gal (SA-β-gal) activity is de-
tected at pH 6 [28,29]. Fibroblasts were additionally stimulated with
doxorubicin, known inducer of cellular senescence and Nrf2 activity.
Our data shows that β-gal activity at pH 7 is detected above background
only in lysates from tKO ﬁbroblasts stimulated with doxorubicin (Fig.
S1A). Importantly, it remains undetectable in in situ staining at pH 7
(Fig. S1B), which suggests that detection of LacZ-derived β-gal activity
can be only achieved in lysates at pH 7. Accordingly, the blue color of
cells stained in situ at pH 6 may come only from SA-β-gal activity (Fig.
S1C). In agreement, activity of LacZ-derived β-gal remains below the
level of detection in lysates prepared from intact tKO aortas (Fig. S1D)
and in in situ staining (Fig. S1E).
Cell culture. Human aortic endothelial cells (HAECs) (Gibco and
PromoCell) were grown in Endothelial Basal Medium (EBM-2) (Lonza)
supplemented with EGM-2MV SingleQuot Kit Supplements & Growth
Factors (Lonza) and 10% fetal bovine serum (FBS) (EURx). HAECs
isolated from female donor, age 21 were used in the majority of ex-
periments. Two other preparations, isolated from age 21 male and age
23 male donors were used to verify the observed phenotype. Murine
ﬁbroblasts were cultured in DMEM HG (Lonza) containing 10% FBS and
penicillin (100 IU/mL)/streptomycin (100 μg/mL) (Lonza). Cells were
cultured at 37 °C in a humidiﬁed incubator in 5% CO2 atmosphere. The
cells used in all experiments were between passages 5 and 14 to exclude
the induction of senescence by prolonged cell culture.
Transfection with small interfering RNA. Transfections of HAECs
were performed using 50 nM siRNA against human NFE2L2 (Life
Technologies s9493 or siNFE2L2seq2 Life Technologies s9492) or
scrambled siRNA (Life Technologies 4390846) using Lipofectamine™
2000 Transfection Reagent (Life Technologies) in Opti-MEM I Reduced
Serum medium (Life Technologies). After 24 h medium was changed to
EGM-2MV. The experiments were performed 48 h after transfection.
Transfection with siRNA against NOX2 (Life Technologies s3788),
NOX4 (Life Technologies s27013), NOS2 (Life Technologies s9620),
NOS3 (Life Technologies s9623), GAPDH (Life Technologies s5572) and
KEAP1 (Life Technologies s18983 or siKEAP1seq2 Life Technologies
s18982) was performed concomitantly with silencing of NFE2L2.
Oxidant (commonly referred to as reactive oxygen species)
measurement. Oxidants were assessed using 2 methods: MitoTracker
Red CM-H2Xros (Life Technologies) and CellRox Deep Red Reagent
(Life Technologies). The staining was performed according to the
manufacturer's procedure. Data were collected using BD LSR Fortessa.
We recognize that the oxidation of these dyes is only a semi-quantita-
tive estimate of increased oxidant generation and not a true measure-
ment of superoxide or any other oxygen-derived species.
Glutathione level measurement. Assessment of glutathione level
and GSSG/GSH ratio was performed using Glutathione (GSSG/GSH)
Detection Kit (Enzo). The procedure was performed according to
manufacturer's protocol.
Thiobarbituric acid reacting substances (TBARS). In brief, cells
upon treatment or transfection were washed with PBS and then 20%
(w/v) trichloroacetic acid containing 0.8% (w/v) thiobarbituric acid
(Sigma) was added to each well. The cells were scratched oﬀ to the
eppendorf tubes and boiled for 30min. After cooling to room tem-
perature and centrifugation (350 g, 10min), the absorbance of the su-
pernatant at 535 nm and for the nonspeciﬁc turbidity at 600 nmwas
subtracted. The amount of MDA equivalents was calculated using the
extinction coeﬃcient of MDA-TBA complex which is
1.56×105M−1 cm−1 and the results are expressed as pM MDA/mg
protein. We recognize that the TBARS assay is a semiquantitative esti-
mate of the oxidation of molecules, including lipids, that may increase
with oxidative stress rather than a true measurement of lipid perox-
idation.
Detection of O2•- in the isolated aorta or cells in vitro. Oxidation
of dihydroethidium (DHE) to 2-hydroxy-ethidium (2-OH-E+) was used
as an indicator of superoxide radical anion (O2•-) production in HAECs
and aortas. The freshly harvested aorta was carefully cut out and
cleaned from any adherent tissues, opened longitudinally, and placed in
wells of a 48-well plate, each well ﬁlled with 100 μL of 10 μM DHE in
PBS buﬀer without Ca/Mg ions pH 7.4 and incubated for 45min at
37 °C in the dark. Then it was immediately frozen in liquid nitrogen in
light safe tubes and stored in −80 °C until used. Aorta samples were
homogenized in 250 μL of 0.1% Triton X-100 in ice-cold DPBS buﬀer
and then centrifuged for 5min at 1000 g at 4 °C to obtain supernatant.
In order to extract the oxidation products of DHE 200 μL of supernatant
was transferred to a fresh tube and mixed with 100 μL of 0.2M HClO4 in
methanol. The samples were incubated on ice for 2 h and subsequently
centrifuged for 30min at 16,600 g at 4 °C. A volume of 120 μL of the
supernatant was then transferred to a fresh tube containing 120 μL of
1M phosphate buﬀer (pH 2.6). This solution was centrifuged for an
additional 15min at 16,600 g at 4 °C. A volume of 200 μL of the su-
pernatant was transferred to HPLC vials for analysis.
Conﬂuent HAEC cells (85mm dishes) were incubated for 30min
with 10 μM DHE in cell culture medium without FBS at 37 °C in a fully
humidiﬁed atmosphere of 5% CO2. All subsequent manipulations were
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performed on ice. Followed by washing with an ice-cold DPBS, the cells
were scrapped in 1mL of DPBS and centrifuged for 5min at 1000 g at
4 °C. The supernatant was removed and 150 μL of DPBS containing
0.1% Triton X-100 was added. The cells were lysed using an insulin
syringe (10 times) and centrifuged for 5min at 1000 g at 4 °C. The vo-
lume of 2 μL of the supernatant was used for protein determination
using BCA assay; the volume of 100 μL of supernatant was transferred
into the tube containing 100 μL of 0.2M HClO4 in MeOH, vortexed
(10 s) and placed back on the ice for protein precipitation. After 1–2 h
the samples were centrifuged for 30min at 16,600 g at 4 °C and 100 μL
of supernatant was transferred into the tube containing 100 μL of 1M
phosphate buﬀer pH 2.6, vortexed (5 s) and centrifuged for 15min at
16,600 g at 4 °C. A volume of 150 μL of the supernatant was transferred
into HPLC vials for analysis. Measurement of 2-OH-E+ was performed
by HPLC technique with ﬂuorescence detection using Ultimate3000
Dionex system (Thermo, USA). Chromatographic separation was car-
ried out on an analytical column Kinetex C18 (4.6×100 mm, 2.6 μm,
Phenomenex, USA) with the oven temperature set at 40 °C. The mobile
phase consisted of acetonitrile (A) and water (B) both with an addition
of 0.1% triﬂuoroacetic acid with the following linear eluting steps:
0.0 min (A:B, 25/75, v/v) – 0.5 min (A:B, 25/75, v/v) – 8min (A:B, 35/
65, v/v) – 9min (A:B, 95/5, v/v) – 11min (A:B, 95/5, v/v) – 12.0 min
(A:B, 25/75, v/v) – 14.0 min (A:B, 25/75, v/v). The ﬂow rate was set at
1mLmin−1. A sample volume of 50 μL was injected onto column. The
concentration of 2-OH-E+ (corresponding to the concentration of O2•-
generated in samples) was calculated from a standard curve and nor-
malized to total protein concentration.
Quantitative RT-PCR. RNA was isolated using RNeasy Mini Kit
(Qiagen). Reverse transcription reaction was carried out using High
Capacity cDNA Reverse Transcription Kit (Life Technologies). The
procedures were performed according to the vendor's instructions.
Quantitative RT-PCR was performed in a StepOnePlus real-time PCR
system (Applied Biosystems) using SYBR Green PCR Master Mix
(Sigma). Sequences of primers are given in Table S1.
EPR measurement of ˙NO in the isolated aorta and in cells in
vitro. For measurements of ˙NO, EPR spin-trapping with diethyldithio-
carbamic acid sodium salt (DETC) was used. Brieﬂy, Krebs–HEPES
buﬀer (consisting of, in mM: NaCl 99.0; KCl 4.7; MgSO4·7 H2O 1.2;
KH2PO4 1.0; CaCl2·H2O 2.5; NaHCO3 25.0; glucose 5.6; and Na-Hepes
20.0) was ﬁltered through a 0.22 μm paper syringe ﬁlter and equili-
brated to pH 7.4, then deoxygenized by bubbling argon gas for at least
30 min. DETC (3.6 mg) and FeSO4 · 7H2O (2.25 mg) were separately
dissolved under argon gas bubbling in two 10mL volumes of ice-cold
Krebs–HEPES buﬀer and were kept under gas ﬂow on ice until used.
One half (upper segment) of freshly harvested aortas was cleaned from
adherent tissue, opened longitudinally, and placed in wells of the 48-
well plate, each ﬁlled with 100 μL Krebs–Hepes and preincubated for
30min at 37 °C. DETC and FeSO4 · 7 H2O solutions were mixed 1:1 (v/
v) to obtain 250 μL Fe(DETC)2 colloid per well (ﬁnal concentration
285 μM) and immediately added to the aorta in parallel with calcium
ionophore A23187 (ﬁnal concentration 1 μM) to stimulate eNOS and
subsequently incubated at 37 °C for 90min. In some cases, the addition
of calcium ionophore was omitted, to show the unstimulated formation
of ˙NO–Fe(DETC)2. After incubation, each aorta was removed from the
buﬀer, drained on a piece of Kimwipe for 5 s and the wet mass was
measured. Next the aorta was frozen, in liquid nitrogen, into the middle
of a 400 μL column of Krebs–HEPES buﬀer and stored in −80 °C until
measured.
Conﬂuent HAEC cells (10 cm dishes) were washed with DPBS and
600 μL of culture medium without FBS was added. 200 μL of freshly
prepared Fe(DETC)2 colloid was added into the dishes and the cells
were incubated for 60min at 37 °C in fully humidiﬁed atmosphere of
5% CO2, followed by discarding the medium containing the spin trap,
collection of the cells by scraping into 1-mL insulin syringe (300 μL per
sample) and snap freezing in liquid nitrogen.
EPR spectra were obtained in liquid nitrogen in a ﬁnger Dewar
using an X-band EPR spectrometer (EMX Plus, Bruker) and were
quantiﬁed by measuring the total amplitude of the ˙NO–Fe(DETC)2 after
correction of baseline. ˙NO production was calculated from a standard
curve prepared using MAHMA-NONOate donor and samples were
normalized to the weight of the wet aorta.
Intracellular ˙NO. Intracellular ˙NO was measured using ﬂuorescent
probe DAF FM (Life Technologies) according to manufacturer's pro-
tocol. The data was collected on BD LSR Fortessa cytometer.
Measurement of nitrosylhemoglobin in blood. The concentration
of nitrosylhemoglobin was measured by electron paramagnetic re-
sonance (EPR). Blood was drawn from the right heart ventricle to a
heparinized syringe (nadroparin, 10 U/mL) and EPR spectra of isolated
erythrocytes (snap-frozen isolated erythrocytes (RBCs) obtained from
whole blood via centrifugation at 1000g and 4 °C for 5min) were re-
corded in liquid nitrogen (77 K) by using an EMX EPR Burker spectro-
meter operating at a frequency of 9.45 GHz, with the power of
15.98mW, modulation amplitude equal to 5 G, time constant of 81.92 s,
and sweep time of 20.48 s in the range of 200 G. For each sample, 30
individual scans were averaged. NOHb levels were expressed as ˙NO per
mg RBCs, were calculated from standard curve samples prepared by
incubating washed RBCs with various concentrations of PAPA-
NONOate donor at 37 °C for 30min [30].
Measurement of S-nitrosation by chemical reduction/chemilu-
minescence. The cells were lysed in PBS with 1% NP-40 (Sigma
Aldrich), 1 mM diethylenetriaminepentaacetic acid (Sigma Aldrich) and
0.2 mM neucuproine (SigmaAldrich), centrifuged 10min, 14,000 g. For
detection of SNO, NO was displaced from S–NO bonds by mercuric ion
(HgCl2) and measured using the Sievers NOA 280i nitric oxide analyzer,
as described by Manning and Schonhoﬀ [31]. Each sample was divided
into two equal aliquots and incubated for 5min at room temperature in
the dark with either HgCl2 (ﬁnal concentration 5mM) or vehicle
(deionized water). All samples were prepared with the addition of 1mM
EDTA to chelate free metals, that might interfere with SNO detection.
Next, 50 μL of each sample was introduced into the reaction chamber of
the nitric oxide analyzer, ﬁlled with 5mL of glacial acetic acid, 1 mL of
KI solution (50mg per mL water) and antifoaming agent, using an
airtight Hamilton syringe. The concentration of ˙NO in each sample was
calculated based on a calibration curve. The addition of HgCl2 and/or
EDTA did not modify the pH of samples, nor did it inﬂuence the cali-
bration curve slope. The increase in the ˙NO content between HgCl2-
treated and vehicle-treated aliquots of each sample is the SNO-speciﬁc
signal, which is expressed as nM per mg protein.
Detection of S-nitrosation by biotin switch assay. The procedure
was performed as described in Forrester et al. [32]. For immuno-
ﬂuorescence detection of S-nitrosated proteins streptavidin conjugated
to Alexa Fluor 568 or Alexa Fluor 488 (Life Technologies) was used.
High-resolution images were taken using a meta laser scanning confocal
microscope (LSM-510; Carl Zeiss). Due to the controversy raised on the
speciﬁcity of biotin switch assay [33,34], quantitative chemilumines-
cence-based SNO measurement was done and additional controls with
DTT, ascorbate and GSNO + cysteine for biotin switch assay were
performed.
Detection of S-nitrosation by Western blotting. The amount of
total S-nitrosated proteins in cells was detected by Pierce S-nitrosation
Western Blot Kit (Life Technologies) according to vendor's procedure.
The assay is based on a modiﬁed biotin switch assay, in which cysteine-
speciﬁc iodoTMT (tandem mass tag) is used instead of biotin. The
membrane is probed with anti-TMT antibody to detect the S-nitrosated
proteins. Due to the controversy raised on the speciﬁcity of biotin
switch assay [33,34], quantitative chemiluminescence-based SNO
measurement was done and additional controls with DTT, ascorbate
and GSNO + cysteine for biotin switch assay were performed.
8-isoprostane measurement. 8-isoprostane was measured using
OxiSelect™ 8-iso-Prostaglandin F2α ELISA Kit (Cell Biolabs) according
to manufacturer's protocol. We recognize that this antibody may also
recognize closely related lipid oxidation products.
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Neutral comet assay. For measurement of double-strand breaks
Trevigen CometAssay (Trevigen) was used according to the manufac-
turer's protocol. The high-resolution photos were taken using confocal
microscope with meta-scanner (LSM-510, Carl Zeiss). Level of DNA
damage was assessed using Instem – Comet Assay IV measurement
system for the comet assay.
Isolation of ﬁbroblasts. 5-day old pups were sacriﬁced by decap-
itation and lungs were collected. After tissue fragmentation, lungs were
digested in 4 U/mL dispase (Gibco) for 45min. After enzyme neu-
tralization, cells were centrifuged and seeded onto plates. After 4 days,
the cells were passaged and seeded for the experiment. LacZ-driven β-
galactosidase activity was measured using the β-Galactosidase Enzyme
Assay with Reporter Lysis Buﬀer (Promega).
En face immunostaining. For en face immunostaining, the mice
were perfused with 1% PFA. Whole aortas were removed, gently
cleaned of perivascular fat and ﬁxed for 15min with 4% paraf-
ormaldehyde (PFA). Next, aortas were incubated for 3 h in blocking
permeabilizing buﬀer (0.3% Triton X-100, 5% goat serum, 1% BSA) and
then incubated overnight with primary antibody targeting Keap1
(Clone 144, Millipore) in buﬀer (0.1% Triton X-100, 1% goat serum).
Thereafter, the aortas were incubated for 2 h with secondary antibody
conjugated with Alexa Fluor 568 (Life Technologies). After washing,
the aortas were opened, intima facing up and mounted with Dako
Fluorescence Mounting Medium (Dako). High-resolution images were
taken using a meta laser scanning confocal microscope (LSM-510; Carl
Zeiss).
Immunoﬂuorescence. HAECs were seeded on coverslips. After
stimulation, the cells were shortly washed in PBS, ﬁxed for 10min in
80% methanol and washed 3 times in PBS. Afterwards, the cells were
incubated in 0.25% glycine in PBS for 30min at room temperature and
washed 3 times in PBS, then blocked in 3% BSA in PBS for 1 h at room
temperature. The cells were probed with primary antibody (anti-Keap1
Millipore, anti-GAPDH Santa Cruz, anti-NOX4 Santa Cruz, anti-iNOS
Santa Cruz, anti-phospho-eNOS (Ser1177) Cell Signaling Technology,
anti-Nrf2 Santa Cruz) in 3% BSA in PBS, overnight at 4 °C. Next day,
cells were 3 times washed in PBS, and incubated with secondary anti-
bodies conjugated with ﬂuorochromes and Hoechst to visualize nuclei.
The slides were mounted with Dako Mounting Medium (Dako). High-
resolution images were taken using a meta laser scanning confocal
microscope (LSM-510; Carl Zeiss).
For the immunoﬂuorescent stainings, the aortas after cleaning from
surrounding tissue were put in OCT Tissue Freezing Medium (Leica)
and frozen in isopentane at −80 °C. Then, 16 μm slides were cut in
cryostat (Leica) and put on poly-L-lysine-covered slides. The slides were
ﬁxed for 10min in 80% methanol and washed 3 times in PBS.
Afterwards, the slides were incubated in 0.25% glycine in PBS for
30min at room temperature and washed 3 times in PBS, then blocked
10% goat serum in PBS for 1 h at room temperature. The aortas were
probed with primary antibody against p21 (Santa Cruz) in 1% goat
serum in PBS, overnight at 4 °C. Next day, cells were 3 times washed in
PBS, and incubated with secondary antibodies conjugated with ﬂuor-
ochrome. The slides were mounted with Dako Mounting Medium
(Dako). High-resolution images were taken using a meta laser scanning
confocal microscope (LSM-510; Carl Zeiss).
Staining for SA-β-galactosidase activity. Cells or aortas were
ﬁxed for 3min with 4% formaldehyde, washed twice with PBS and
incubated overnight at 37 °C with staining solution (5mM potassium
ferricyanide, 5 mM potassium ferrocyanide, 150mM NaCl, 2 mM
MgCl2, 1 mg/mL X-gal in citrate buﬀer pH 6).
Assessment of cell proliferation. Cells were stained for PCNA
antigen, as described previously [23].
Transduction with adenoviral vectors AdGFP and AdNFE2L2DN.
The transductions with adenoviral vectors AdNFE2L2DN or AdGFP were
performed at a multiplicity of infection 50. AdNFE2L2DN vectors code
403–605 aa of Nrf2: domains Neh2 (Keap1 binding), Neh4 and Neh5
(transactivating domains), Neh7 (RXRa binding) and Neh6 (TrCP
binding) are missing, but Neh1 (DNA binding) and Neh3 (CHD6
binding) are present. After 24 h of incubation, medium with vectors was
removed and fresh EGM-2MV 10% FBS complete medium was added
for the next 24 h. The eﬃciency of transduction was conﬁrmed by de-
tection of GFP expression with the ﬂuorescent microscope and by as-
sessment of mRNA level of Nrf2 target genes.
Shear stress conditions. For the shear stress experiments, HAECs
were sheared orbitally at 300 rpm for 24 h at 37 °C in a humidiﬁed in-
cubator in 5% CO2 atmosphere. The eﬀect of orbital shear stress reﬂects
the one seen in the disturbed and turbulent ﬂow [35]. This sort of shear
stress can be seen in the regions of bifurcations, bends and branches.
There is an increased number of senescent endothelial cells and ac-
celerated aging at the sites of disturbed ﬂow [36]. Also Nrf2 activity
and nuclear translocation are the same in orbital shear stress and dis-
turbed/oscillatory shear stress. In contrast to laminar shear stress (L-
ﬂow), in oscillatory (O-ﬂow) conditions Nrf2 does not bind to EpRE,
although it translocates into nuclei in both L-ﬂow and O-ﬂow [37]. In
our model of shear stress Nrf2 is localized preferentially in the nuclei
but remains transcriptionally inactive, as the expression of Nrf2 target
genes remained comparable between cells subjected to static and or-
bital shear stress conditions (Fig. S2).
Measurement of nitrite in media - Griess assay. Collected media
were incubated for 30min 1:1 with a mixture containing 0.2% naph-
thylethylenediamine dihydrochloride and 2% sulphanilamide in 5%
phosphoric acid. Absorbance was measured at 530 nm using Tecan
Spectra II Microplate Reader (Tecan).
Western blotting. Total protein was isolated using RIPA buﬀer
with protease inhibitors (50mM Tris-HCl pH 8.0, 150mM NaCl, 1%
NP-40, 0.5% Na-deoxycholate, 0.1% SDS). Western blotting was per-
formed according to standard procedures. Membranes were probed
with antibodies against Nrf2 (Santa Cruz Biotechnology), p21 (Cell
Signaling Technology), phospho-eNOS (Ser 1177) (Cell Signaling
Technology), eNOS (Cell Signaling Technology), and tubulin
(Calbiochem).
Co-immunoprecipitation. The proteins were crosslinked with
500 μM dithiobis succinimidyl propionate (DSP, Thermo Scientiﬁc
Pierce) for 30min, RT. The reaction was quenched with 50mM Tris, pH
7.5. The cells were lysed in RIPA buﬀer (Pierce), containing protease
and phosphatase inhibitors (Roche). The lysates were incubated with
2 μM of rat anti-Keap1 antibody or 2 μM of rat IgG antibody (BD)
overnight at 4 °C. The proteins were pulled down using goat anti-rat
Magnetic Beads (New England's Biolabs). The eluted proteins were se-
parated by SDS-PAGE. The membranes were probed with anti-GAPDH
antibody (Santa Cruz Biotechnology) and anti-phospho(Ser1177)-eNOS
antibody (Cell Signaling Technology).
Measurement of nitrate and nitrite in plasma. The concentra-
tions of nitrate and nitrite were measured by HPLC NOx analyzing
system ENO-20 (Eicom), as described previously [38].
Identiﬁcation of S-nitrosated proteins by mass spectrometry
analysis. S-nitrosated proteins were pulled down using the biotin
switch assay. Precipitated proteins were processed as described pre-
viously [23]. Label-Free-Quantiﬁcation (LFQ) intensity values were
calculated using the MaxLFQ algorithm. Data were normalized and
analyzed using Scaﬀold 4.8.2 ProteomeSofware platform. The mass
spectrometry proteomics data have been deposited to the Proteo-
meXchange Consortium via the PRIDE partner repository.
Stimulation of cells. HAECs were stimulated with 1 mM N-acetyl
cysteine (NAC) pH 7.4, 50 μM TEMPOL, 5 mM DTT, 200 μM S-ni-
trosoglutathione (GSNO) + 50 μM cysteine, 100 μM etoposide, 10 μM
antimycin or 5 mM ascorbate in EGM-2MV medium. Stimulation of
HAECs with TEMPOL, DTT, antimycin or ascorbate was done for 24 h,
with GSNO + cysteine for 15 min, with FeCitrate for 30 min, and with
etoposide for 1.5 h. In case of NAC, the cells were prestimulated for 2 h,
and then NAC was withdrawn for 6 h. All reagents were purchased from
Sigma.
Statistical Analysis. All experiments were performed in duplicates
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and were repeated at least three times. Data are presented as
mean ± SEM. Statistical assessment was done with Student's t-test for
two group comparisons or by analysis of variance (ANOVA), followed
by a Bonferroni posthoc test for multiple comparisons. Diﬀerences were
accepted as statistically signiﬁcant for p < 0.05.
3. Results
Inhibition of Nrf2 transcriptional activity results in premature
senescence, but not oxidative damage, in murine aorta. To verify if
disruption of Nrf2 signaling drives senescent phenotype of vascular
cells in vivo, aortas of 8-week old wild type (WT) and transcriptional
knock out (tKO) mice were stained for senescence-associated β-ga-
lactosidase (SA-β-gal) activity. We found that it was profoundly in-
creased in tKO aortas, compared to WT animals, and present
throughout the whole length of the vessels (Fig. 1A). En face projection
showed the appearance of SA-β-gal positive cells at the luminal surface
of the vessels, which were also massively scattered across the whole
depth of the aortic wall, including tunica intima and tunica adventitia
(Fig. 1B). Moreover, a signiﬁcant gain of p21, the senescence-mediating
protein, was seen in the aortas of tKO mice (Fig. 1C). Considering the
key role of Nrf2 signaling in the regulation of oxidative defense [8], and
the mechanism of premature senescence induction by oxidative stress
[39], oxidative status of WT and tKO aortas was assessed. No diﬀer-
ences in glutathione peroxidase (Gpx1), manganese superoxide dis-
mutase (Sod2) and catalase (Cat) expression were detected between the
aortic tissue of WT and tKO animals (Figs. 1D–F). The superoxide anion
level was elevated by ~1.6 fold in the aortas of tKO mice (Fig. 1G), but
TBARS, which are an estimate of oxidative damage, were equal be-
tween WT and tKO aortas (Fig. 1H). Signiﬁcant increase of TBARS was
observed for aortas challenged with iron overload, which served as a
positive control for the assay (Fig. 1H). These data demonstrate that
inhibition of Nrf2 transcriptional activity does not cause damaging
oxidative stress in the murine aorta and results in the senescence onset.
Loss of Nrf2 protein in primary human ECs is not associated
with excessive oxidative stress. Similarly to Nrf2 tKO aortas, TBARS
remained low in siNFE2L2-transfected HAECs, with the level compar-
able to siMock cells (Fig. 2A). In accordance, 8-isoprostane, another
marker of oxidative damage, was low and equal between siMock and
siNFE2L2 cells (Fig. 2B), and level of double-strand DNA breaks (DSB)
was also comparable for both groups (Fig. 2C). Antimycin and etopo-
side treatments were used as positive controls for increased 8-iso-
prostane and DSB, respectively (Figs. 2B and C). No changes in the
expression of GPX1 (Fig. 2D), but signiﬁcant downregulation of SOD2
(Fig. 2E) and CAT (Fig. 2F) transcripts were observed upon silencing of
NFE2L2 in HAECs. Even so, neither total (Fig. 2G) nor mitochondrial
(Fig. 2H) oxidation of ﬂuorescent probes, were found to be elevated in
Nrf2-deﬁcient cells and their total antioxidant capacity was preserved
(Fig. 2I). The HPLC-based analysis showed a tendency of 25% increase
in superoxide anion amount in siNFE2L2 HAECs (Fig. 2J). Analysis of
potential superoxide sources (uncoupled eNOS, NOX2 and NOX4) re-
vealed no signiﬁcant diﬀerences between inspected groups, however
concomitant silencing of NOX2 and NOX4 in Nrf2-deﬁcient cells caused
the strongest tendency toward decreased superoxide (Fig. 2J). Total
glutathione level was lower in Nrf2-deﬁcient HAECs (Fig. 2K), while the
disulﬁde form of glutathione was undetectable. GSSG was likely ex-
ported to account for the decreased total glutathione. Such results may
be indicative of a redox status that only slightly shifted towards oxi-
dation in HAECs lacking Nrf2. Thus, Nrf2 deﬁciency in HAECs does not
result in oxidative damage. Finally, we made an attempt to rescue the
senescent phenotype of Nrf2-deﬁcient cells (Fig. 2L) by incubation with
N-acetylcysteine (NAC), a known glutathione precursor that supplies
cysteine, which is normally limiting for glutathione synthesis. NAC
triggered only partial attenuation of SA-β-gal activity in HAECs with
siRNA-mediated knockdown of Nrf2 (Fig. 2L). Incubation of cells with
non-toxic concentration of the superoxide scavenger TEMPOL did not
Fig. 1. Senescence, but no oxidative damage is present in Nrf2 tKO aortas.
(A) Assessment of SA-β-gal activity in aortas from WT and Nrf2 tKO mice. Representative pictures. n=8. Scale bar 4 mm.
(B) En face projection of aortas from WT and Nrf2 tKO mice stained for SA-β-gal activity. Representative pictures. n= 5. Scale bar 0.35mm.
(C) p21 level in WT and Nrf2 tKO aortas. Representative pictures. n=6. Scale bar 0.2mm. Insets – negative control.
(D–F) Expression of Gpx1 (D), Sod2 (E) and Cat (F) in aortas fromWT and Nrf2 tKO mice. Relative expression of genes was measured by real-time PCR. EEF2 served as
a reference gene. n=7–8.
(G) Assessment of superoxide anion level in WT and Nrf2 tKO aortas by HPLC measurement of 2-OH-E+, the superoxide-derived oxidation product of DHE.
∗∗∗p < 0.001 vs WT, n=7–8, two-tailed Student's t-test.
(H) Measurement of TBARS in WT and Nrf2 tKO aortas. The specimens were treated with 5 μM FeCitrate (a positive control) for 30min. MDA was measured using
thiobarbituric acid assay. ∗∗∗p < 0.001 vs PBS, ##p < 0.01 vs WT. n = 5–10, two-way ANOVA + Bonferroni's.
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Fig. 2. Loss of Nrf2 in HAECs does not result in oxidative damage.
(A) Measurement of TBARS in siMock and siNFE2L2 HAECs. Cells were treated with 5 μM FeCitrate (a positive control) for 1 h. MDA was measured using thio-
barbituric acid assay. n= 3, ∗∗∗p < 0.001 vs PBS, two-way ANOVA + Bonferroni's.
(B) 8-isoprostane level in siMock and siNFE2L2 HAECs measured by ELISA. Cells were treated with 10 μM antimycin (a positive control) for 24 h. n= 3, ∗∗p < 0.01
vs PBS, ∗∗∗p < 0.001 vs PBS, two-way ANOVA + Bonferroni's.
(C) Percentage of DNA in tail in siMock and siNFE2L2 HAECs. Neutral comet assay. Cells were treated with 100 μM etoposide (a positive control) for 1.5 h.
n= 115–209, ∗∗∗p < 0.001 vs DMSO, ###p< 0.001 vs siMock, two-way ANOVA + Bonferroni's.
(D–F) Expression of GPX1 (D), SOD2 (E) and CAT (F) in siMock and siNFE2L2 HAECs. Relative expression of genes was measured by real-time PCR. EEF2 served as a
reference gene. ∗p < 0.05 vs siMock. n= 17, two-tailed Student's t-test.
(G–H) Total (G) and mitochondrial (H) ROS level in siMock and siNFE2L2 HAECs was assessed by ﬂuorescent probe using ﬂow cytometry. n= 7–9.
(I) Assessment of total antioxidant capacity of siMock and siNFE2L2 HAECs. n= 3.
(J) Assessment of superoxide anion level in siMock/siMock, siMock/siNFE2L2, siNOS3/siNFE2L2, siNOX2/siNFE2L2, siNOX4/siNFE2L2 and siNOX2/4/siNFE2L2
HAECs by HPLC measurement of 2-OH-E+, the superoxide-derived oxidation product of DHE. n= 3–6.
(K) Total glutathione level in siMock and siNFE2L2 HAECs. ∗p < 0.05 vs siMock. n= 4, two-tailed Student's t-test.
(L) Percentage of cells with increased SA-β-gal activity in siMock and siNFE2L2 HAECs treated with N-acetylcysteine (NAC). Cells transfected with control (siMock)
or NFE2L2 (siNFE2L2) siRNA were treated for 2 h with 1mM NAC and left for 6 h for the reversion of signaling. n= 4, ∗∗∗p < 0.001 vs siMock, ###p < 0.001 vs
siNFE2L2, two-way ANOVA + Bonferroni's.
(M) Percentage of cells with increased SA-β-gal activity in siMock and siNFE2L2 HAECs treated with TEMPOL. Cells transfected with control (siMock) or NFE2L2
(siNFE2L2) siRNA were treated for 24 h with 50 μM TEMPOL. n= 4, ∗∗∗p < 0.001 vs siMock, two-way ANOVA + Bonferroni's.
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reverse the senescent phenotype of HAECs (Fig. 2M). Collectively, these
data show that Nrf2-deﬁcient HAECs do not encounter excessive oxi-
dative stress and damage. Although their microenvironment shows mild
disequilibrium towards oxidation, it is not harmful to the cells. There-
fore, the major cause of HAEC senescence driven by knockdown of Nrf2
is not linked to the uncontrolled oxidative stress.
Lack of Nrf2 transcriptional activity induces premature senes-
cence but only in shear stress conditions. The animal model of Nrf2
deﬁciency used in this study, and broadly used worldwide, is a tran-
scriptional knockout, in which DNA binding domain of Nrf2 had been
removed, but the N-terminal fragment of Nrf2, containing Keap1
binding domain Neh2, is preserved [23,24]. On the other hand, in
siRNA-based in vitro experimental setting (Fig. 2) the availability of
Nrf2 protein is reduced [23]. Moreover, our recent study indicates that
Nrf2 activity may reach beyond transactivation of gene expression, as
the constant synthesis of Nrf2 occupies Keap1 thereby preventing an-
giogenic dysfunction in ECs [23]. Therefore, to compare the ﬁndings
from in vivo setting (Fig. 1) with in vitro experiments (Fig. 2), HAECs
were transduced with adenoviral vectors harboring dominant-negative
NFE2L2, coding C-terminal fragment of Nrf2 (domains Neh1 and Neh3),
which is transcriptionally inactive [23]. The non-toxic titer of Ad-
NFE2L2DN vectors led to ~60% inhibition of Nrf2 transcriptional ac-
tivity, assessed by the mRNA level of its target genes NQO1 and GCLM
(Figs. 3A and B), however it did not result in the onset of senescence
(Fig. 3C), unless the cells were subjected to the orbital shear stress
conditions (Fig. 3C). The decrease in proliferation marker PCNA was
not reversed by treatment of the cells with TEMPOL (Fig. 3D). Taken
together, loss of Nrf2 signaling in sheared cells induces senescence
onset in vitro in HAECs and in vivo in the murine aorta, but ECs devoid
of Nrf2 protein develop a senescent phenotype even in static conditions.
Nrf2-dependent senescence onset is associated with potent
protein S-nitrosation. Premature cellular senescence can be triggered
by markedly increased S-nitrosation of proteins, which impairs multiple
cellular processes [3,40,41]. Thus we considered that S-nitrosation
might be responsible for the induction of senescent phenotype in en-
dothelial cells with disturbed Nrf2 signaling. Furthermore, we hy-
pothesized that its functional role in these cells is protection from
oxidative damage.
In comparison to WT, tKO aortas exhibited an increased level of S-
nitrosation (Fig. 4A), together with the signiﬁcant downregulation of
genes Adh5 (Fig. 4B) and Txnrd1 (Fig. 4C), coding denitrosating en-
zymes GSNOR and TrxR1, respectively. Analysis of ˙NO metabolism
showed lower nitric oxide functional release in the aortic wall upon
stimulation with calcium ionophore (Figs. 4D and S6), decreased
amount of nitrosylhemoglobin in erythrocytes (Figs. 4E and S7) to-
gether with unchanged nitrites (Fig. 4F), but raised nitrates, the pro-
ducts of nitrite oxidation (Fig. 4G), in plasma of Nrf2 tKO mice.
Likewise, silencing of NFE2L2 expression in HAECs resulted in a
potent S-nitrosation of proteins (Fig. 5A). Nitrotyrosines, however,
were undetectable, which excludes the presence of excessive nitrosative
stress in these cells. The intracellular level of ˙NO, measured by DAF FM
probe, was raised by ~30% in Nrf2-deﬁcient cells due to eNOS and
iNOS activity (Fig. 5B). Cellular ˙NO concentration, measured by EPR
with hydrophobic spin trap DETC, was equal between compared groups
(Fig. 5C), whereas the level of secreted nitrites, direct products of ˙NO
oxidation, was lower in Nrf2-deﬁcient cells (Fig. 5D). Although ex-
pression of NOS3, coding endothelial NOS (eNOS), decreased on the
mRNA and protein level (Figs. 5E and F), eNOS activating phosphor-
ylation of serine 1177 was strengthened (Fig. 5F). NOS2 gene expres-
sion, coding inducible NOS (iNOS) remained unchanged (Fig. 5G), but
iNOS protein was strongly elevated in Nrf2-deﬁcient cells (Fig. 5H). The
speciﬁcity of anti-iNOS antibody was veriﬁed (Fig. S3A). Finally, a
profound downregulation of ADH5 (Fig. 5I) and TXNRD1 (Fig. 5J) ex-
pression was observed in HAECs devoid of Nrf2.
Overexpression of NFE2L2DN in HAECs in static conditions only
subtly increased protein S-nitrosation (Figs. 5K and L), which was
accompanied by the unchanged level of ADH5 mRNA (Fig. 5M) and a
signiﬁcant decrease of TXNRD1 (Fig. 5N). Culture of HAECs in sheared
conditions induced protein S-nitrosation both in GFP- and NFE2L2DN-
transduced cells; however, the level of this modiﬁcation was much
stronger in AdNFE2L2DN HAECs (Fig. 5L). Increased S-nitrosation and
SA-β-gal activity were seen in sheared AdNFE2L2DN in the entire well.
Analysis of gene expression of denitrosating enzymes revealed that
stress conditions downregulated ADH5 only in AdNFE2L2DN cells
(Fig. 5M), while TXNRD1 mRNA level was lower in AdNFE2L2DN cells
in comparison to AdGFP regardless of ﬂow conditions (Fig. 5N).
Collectively, these results demonstrate the presence of exacerbated
S-nitrosation in Nrf2-deﬁcient HAECs, NFE2L2DN overexpressing HAECs
subjected to orbital shear stress, and in Nrf2 tKO aortas when the onset
of senescence is observed. Moreover, intensiﬁed S-nitrosation and se-
nescence occur uniquely when the expression of both genes coding
denitrosylating enzymes, ADH5 and TXNRD1, is downregulated.
Therefore, taking the next step, we aimed to determine the functional
Fig. 3. Inhibition of Nrf2 transcriptional activity together with subjection
to shear stress conditions results in a senescence onset in HAECs.
(A–B) Expression of NQO1 (A) and GCLM (B) in HAECs transduced with
dominant negative NFE2L2 at MOI 50. Relative expression of genes was mea-
sured by real-time PCR. EEF2 served as a reference gene. ∗∗∗p < 0.001 vs
AdGFP. n= 4–5, two-tailed Student's t-test.
(C) Percentage of cells with increased SA-β-gal activity in HAECs transduced
with dominant negative NFE2L2 at MOI 50. Cells were subjected for 24 h to
shear stress conditions. n= 3, ∗∗∗p < 0.001 vs static, ###p < 0.001 vs AdGFP,
two-way ANOVA + Bonferroni's.
(D) PCNA immunoﬂuorescent staining in HAECs transduced with dominant
negative NFE2L2 at MOI 50 and treated for 24 h with 50 μM TEMPOL. Cells
were subjected for 24 h to shear stress conditions. Quantitative data. n= 3,
∗p < 0.05 vs static, ∗∗∗p < 0.001 vs static, ###p < 0.001 vs AdGFP, two-way
ANOVA + Bonferroni's.
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signiﬁcance of S-nitrosation in Nrf2-deﬁcient ECs.
S-nitrosation provides protection from NOX4-mediated oxida-
tive stress and death in Nrf2-deﬁcient cells. The role of S-nitrosation
in endothelial physiology remains elusive. It is an essential protein
modiﬁcation to maintain endothelial homeostasis [21]. On the other
hand, it contributes to the impairment of various cellular processes,
thus leading to senescence onset [42]. To address this issue, the cells
were incubated with dithiothreitol (DTT), the reducing agent, which
entirely abolished protein S-nitrosation (Fig. 6A). Such treatment led to
oxidative damage assessed by an increase in TBARS (Fig. 6B) and
sudden Nrf2 deﬁcient cell death (Fig. 6C), which was not the case in
siMock HAECs (Figs. 6B and C). This shows that S-nitrosation protects
Nrf2-deﬁcient ECs from oxidative injury and death.
In the pursuit of the possible mechanism of S-nitrosation based
protection of ECs, mass spectrometry analysis was performed to identify
modiﬁed proteins. Among 28 SNO-proteins, which appeared pre-
ferentially in siNFE2L2 HAECs (Table S2), NAPDH oxidase 4 (NOX4),
one of the main sources of reactive oxygen species in the cells [43], was
found. As S-nitrosation was shown to inhibit NOX4 activity [44], we
hypothesized that it provides protection from oxidative damage in
HAECs devoid of Nrf2. To address this point, concomitant silencing of
NOX4 and NFE2L2 was performed (Figs. S3B and C). Inhibition of NOX4
expression fully prevented denitrosation-induced oxidative damage in
HAECs cells lacking Nrf2 (Fig. 6D), which successfully hampered DTT-
induced cell death (Fig. 6E). Similarly, stimulation of the cells with
another reducing agent, sodium ascorbate, reversed S-nitrosation of
proteins (Fig. S4A) and induced oxidative damage in siNFE2L2 HAECs
(Fig. S4B), unless the cells were also devoid of NOX4 (Figs. S4C and D).
Thus, we identify S-nitrosation of NOX4 as a mechanism for protection
of Nrf2-deﬁcient ECs from oxidative damage.
Unrestrained Keap1 triggers protein S-nitrosation and pre-
mature senescence in ECs. A prerequisite for the occurrence of in-
creased S-nitrosation and senescence is a lack of Nrf2 protein in static
conditions or a loss of Nrf2 transcriptional activity in shear stress
conditions both in vitro and in vivo. Our group has recently shown that
Keap1 has to be restrained by Nrf2 in ECs to prevent angiogenic dys-
function and that its level is increased, while p62, which Keap1 de-
gradation depends on [45], declines in ECs devoid of Nrf2 [23]. On the
other hand, it is known that exposure of ECs to oscillatory shear stress,
which eﬀects on Nrf2 are similar to orbital shear stress used in the study
(Fig. S2), induces translocation of Nrf2 into the nucleus, although it
remains transcriptionally inactive [37]. Such conditions allow Keap1 to
function in a diﬀerent manner than when it is involved in Nrf2 ubi-
quitination and degradation. Indeed, Keap1 level was increased in
sheared HAECs overexpressing dominant-negative NFE2L2 (Fig. 7A)
and also on the luminal surface of tKO aortas (Fig. 7B) in comparison to
siMock transfected cells and WT mice, respectively. Therefore, we hy-
pothesized that unrestrained and overabundant Keap1 is responsible for
S-nitrosation and premature senescence of ECs. Concomitant silencing
of NFE2L2 and KEAP1 in HAECs decreased protein S-nitrosation
(Fig. 7C), which was conﬁrmed by a direct measurement of SNO using
quantitative chemiluminescence assay (Fig. 7D), and by detection of
SNO-proteins pull downed with biotin switch assay. GSNO-treated
sample served as a positive control (Fig. 7E). Moreover, knockdown of
KEAP1 restored cell proliferation (Fig. 7F), lowered p21 level (Fig. 7G),
and ﬁnally reversed senescent phenotype of Nrf2-deﬁcient cells
(Fig. 7H). Keap1-mediated S-nitrosation was also conﬁrmed in two
other batches of HAECs isolated from diﬀerent donors (Figs. S5A and B)
Fig. 4. Nrf2 tKO aortas exhibit a markedly increased level of S-nitrosation.
(A) Analysis of protein S-nitrosation by immunoﬂuorescent staining in aortas of
WT and Nrf2 tKO mice. The biotin switch assay was used to label S-nitrosated
protein. Detection was done with Alexa Fluor 568 conjugated streptavidin.
Representative pictures. n=5. Scale bar 175 μm.
(B–C) Expression of Adh5 (B) and Txnrd1 (C) in aortas from WT and Nrf2 tKO
mice. Relative expression of genes was measured by real-time PCR. EEF2 served
as a reference gene. ∗p < 0.05 vs WT. n= 8, two-tailed Student's t-test.
(D) Level of nitric oxide in aortas of WT and Nrf2 tKO mice. The aortas were
stimulated with calcium ionophore for 90min and NO level was assessed by
EPR. ∗∗∗p < 0.001 vs DMSO. ##p < 0.01 vs WT, n = 5–7, two-way
ANOVA + Bonferroni's.
(E) Level of nitrosated haemoglobin (HbNO) in the blood of WT and Nrf2 tKO
mice assessed by EPR. ∗p < 0.05 vs WT, n= 7–8, two-tailed Student's t-test.
(F–G) Level of nitrite (F) and nitrate (G) in plasma of WT and Nrf2 tKO mice
assessed by HPLC. ∗p < 0.05 vs WT, n=8–10, two-tailed Student's t-test.
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Fig. 5. Nrf2-dependent senescence onset is associated with potent protein S-nitrosation in HAECs.
(A) Analysis of protein S-nitrosation in siMock and siNFE2L2 transfected HAECs. IodoTMT was used to label S-nitrosated proteins, which were detected by im-
munoblotting. Representative pictures. n=6.
(B) Intracellular NO level in siMock/siMock, siMock/siNFE2L2, siNOS2/siNFE2L2 and siNOS3/siNFE2L2 transfected HAECs measured by ﬂuorescent probe DAF FM.
n = 4, one-way ANOVA + Bonferroni's.
(C) Membrane trapped nitric oxide level in siMock and siNFE2L2 transfected HAECs assessed by EPR. n=3.
(D) Concentration of nitrites secreted within 24 h into media by siMock and siNFE2L2 HAECs. The analysis was performed using Griess assay. ∗∗p < 0.01 vs siMock,
n= 9, two-tailed Student's test.
(E) Expression of NOS3 in HAECs transfected with siMock or siNFE2L2. Relative expression of gene was measured by real-time PCR. EEF2 served as reference gene.
∗∗∗p < 0.001 vs siMock. n=11–12, two-tailed Student's t-test.
(F) Level of total and phospho-Ser1177 eNOS in siMock and siNFE2L2 HAECs. Whole-cell lysates were analyzed by immunoblotting. Tubulin served as a loading
control. Representative example of 3 experiments.
(G) Time course of the expression of NOS2 in HAECs transfected with siMock and siNFE2L2. Relative expression of genes was measured by real-time PCR. EEF2 served
as a reference gene. n=9.
(H) iNOS immunoﬂuorescent staining in siMock and siNFE2L2 HAECs. Representative pictures of 3 experiments. Scale bar 10 μm.
(I–J) Expression of (I) ADH5 and (J) TXNRD1 in HAECs transfected with siMock and siNFE2L2. Relative expression of genes was measured by real-time PCR. EEF2
served as a reference gene. ∗∗∗p < 0.001 vs siMock, n=6, two-tailed Student's t-test.
(K) Analysis of protein S-nitrosation in HAECs transduced with dominant negative NFE2L2 at MOI 50. IodoTMT was used to label S-nitrosated proteins, which were
detected by immunoblotting. Representative picture of 3 experiments.
(L) Analysis of protein S-nitrosation by biotin switch assay with immunoﬂuorescent detection in HAECs transduced with dominant negative NFE2L2 at MOI 50. Cells
were subjected for 24 h to shear stress conditions. Representative picture of 3 experiments. Scale bar 10 μm.
(M–N) Expression of ADH5 (M) and TXNRD1 (N) in HAECs transduced with dominant negative NFE2L2 at MOI 50. Cells were subjected for 24 h to shear stress
conditions. Relative expression of genes was measured by real-time PCR. EEF2 served as reference gene. ∗p < 0.001 vs static, #p < 0.05 vs AdGFP, ###p < 0.001
vs AdGFP, n = 3–15, two-way ANOVA + Bonferroni's.
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and using diﬀerent siRNA sequences targeting NFE2L2 and KEAP1 (Fig.
S5C). Interestingly, silencing of KEAP1 in Nrf2-deﬁcient HAECs did not
bring back expression of ADH5 (Fig. 7I), while restoration of TXNRD1
expression was statistically signiﬁcant, though still low (Fig. 7J). Such a
mild restoration of TXNRD1 expression is rather unlikely to mediate the
reversal of S-nitrosation in siNFE2L2/siKEAP1 cells.
The SNO-proteins formation can be achieved by transnitrosation
due to activity of proximal SNO-modiﬁed proteins – transnitrosases,
which include hemoglobin, thioredoxin, caspase 3, glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) and protein disulphide isomerase
(PDI) [46]. As NO synthase and GAPDH are a part of S-nitrosating
enzymatic complex found in bacteria [20], we analyzed colocalization
of active eNOS, iNOS and GAPDH with Keap1 in HAECs. GAPDH and
iNOS strongly colocalized with Keap1 in siNFE2L2 cells (Figs. 8A and
B), and Ser1177-phosphorylated eNOS/Keap1 colocalization was also
found in these cells (Fig. 8C). In line with blotting analyses (Fig. 5F) and
immunoﬂuorescent staining (Fig. 5H), the levels of activated eNOS and
total iNOS were increased in siNFE2L2 HAECs (Figs. 8B and C). GAPDH
and phospho-eNOS precipitated with Keap1 (Fig. 8D). We were also
trying to check if iNOS precipitates with Keap1, however the antibody
against iNOS works well in our hands for immunoﬂuorescence (Fig.
S3A), but not for western blotting. Knockdown of every single protein
of the complex Keap1/GAPDH/NOS inhibited S-nitrosation (Fig. 8E).
The question remained, how denitrosation of proteins in Nrf2 deﬁcient
cells redirects them from senescence to apoptosis (Fig. 6), while silen-
cing of Keap1, the protein responsible for the induction of S-nitrosation
and senescence in these cells, restores their normal phenotype (Fig. 7).
Such reliance implicates that NOX4 can be active only when it is de-
nitrosated and Keap1 is present. As depicted in Fig. 8F, NOX4 protein is
abolished in siNFE2L2/KEAP1 cells, which reconciles this discrepancy.
Collectively, these data show that the overabundance of unrestrained
Keap1 causes protein S-nitrosation. In addition, it determines normal,
senescent or apoptotic fate of ECs.
4. Discussion
Studies of the past decade suggested that Nrf2 plays a protective
role against senescence and aging [47]. These associations are con-
sistent across species, including human, rat, mouse, Drosophila mela-
nogaster and Caenorhabditis elegans (CncC and SKN-1 are Nrf2 homologs
in ﬂies and worms, respectively) [48]. Although in the literature no
reports show complete loss of Nrf2 in humans, varying levels of its
activity, especially in aging, is not without signiﬁcance. Detrimental
eﬀects of lower Nrf2 activity are usually attributed to its inﬂuence on
antioxidant mechanisms. In the light of our results, the role of Nrf2 in
the regulation of Keap1 level and its activity should also be taken into
account. Keap1 is degraded by autophagy [45] and one of the Nrf2
target genes is p62, [49] a cargo receptor for autophagosomes. In this
manner, Nrf2 activity may aﬀect Keap1 level. The activity of Nrf2 in
humans is modulated in many ways. NFE2L2 gene is highly poly-
morphic, which is associated with risk and progression of numerous
diseases including cardiovascular ones [48,50,51]. The electrophile
response element (EpRE, also called ARE), a consensus binding se-
quence for Nrf2, can also be polymorphic. This polymorphism may play
a role in the prevention of tauopathies [52,53]. Nrf2 level and its ac-
tivity may decline with age, which was shown in various cell types,
including vascular cells, cardiac cells, epithelial cells and ﬁbroblasts.
The reason for a declined Nrf2 signaling remains unidentiﬁed, though
[48]. Moreover, Nrf2 was shown to be sequestered by progerin and
thereby mislocalized subnuclearly, which impairs its transcriptional
Fig. 6. S-nitrosation provides protection from NOX4-mediated oxidative stress and death in Nrf2-deﬁcient HAECs.
(A) Analysis of protein S-nitrosation in siMock and siNFE2L2 transfected HAECs treated with DTT. Cells were treated with 5mM DTT for 24 h. TMT was used to label
S-nitrosated proteins detected by immunoblotting. Representative picture of 3 experiments.
(B) Measurement of TBARS in HAECs transfected with siMock or siNFE2L2 and treated with 5mM DTT for 24 h. MDA was measured using thiobarbituric acid assay.
n= 3, ∗∗p < 0.01 vs PBS, ##p < 0.01 vs siNFE2L2, two-way ANOVA + Bonferroni's.
(C) Detection of cell death with propidium iodide (PI) staining. Cells were transfected with siMock or siNFE2L2 and treated with 5mM DTT for 24 h n=5.
∗∗∗p < 0.001 vs PBS, ###p < 0.001 vs siNFE2L2, two-way ANOVA + Bonferroni's.
(D)Measurement of TBARS. Cells were cotransfected with siMock, siNFE2L2 or siNOX4 and treated with 5mM DTT for 24 h. MDA was measured using thiobarbituric
acid assay. ∗∗∗p < 0.001 vs control, ###p < 0.001 vs siMock/siMock, $$$p < 0.001 vs siMock/siNFE2L2, n = 3, two-way ANOVA + Bonferroni's.
(E) Detection of cell death with propidium iodide (PI) staining. Cells were cotransfected with siMock, siNFE2L2 or siNOX4 and treated with 5mM DTT for 24 h
∗∗∗p < 0.001 vs control, ###p < 0.001 vs siMock/siMock, $$$p < 0.001 vs siMock/siNFE2L2, n = 5, two-way ANOVA + Bonferroni's.
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activity[14]. Finally, senescence-associated miRNA may repress Nrf2 in
premature aging [54].
The molecular mechanisms of senescence related to the Nrf2 sig-
naling pathway remains open to question, especially in respect to the
cardiovascular system [48]. The overall components of vascular aging
have been reviewed, indicating oxidative stress as the major reason for
age-related vascular impairment [3]. Here, we present that, para-
doxically, the senescent phenotype of endothelial cells and aortas with
deregulated Nrf2 signaling is not accompanied by uncontrollable oxi-
dative stress and damage, even though the steady state superoxide
anion, a modulator of EC function [55], is slightly increased. In the case
of ECs and aortas with Nrf2 impairment, an elevated level of oxidants,
Fig. 7. Keap1 controls protein S-nitrosation and senescent phenotype of HAECs.
(A) Keap1 immunoﬂuorescent staining in AdGFP and AdNFE2L2DN HAECs. Cells were subjected for 24 h to shear stress conditions. Representative picture of 3
experiments. Scale bar 10 μm.
(B) En face immunoﬂuorescent staining of WT and tKO aortas for Keap1. Representative picture of 5 experiments. Scale bar 15 μm.
(C) Analysis of protein S-nitrosation by biotin switch assay with immunoﬂuorescent detection in siMock/siMock, siMock/siNFE2L2 and siKEAP1/siNFE2L2 HAECs.
Representative picture of 3 experiments. Scale bar 10 μm.
(D) Quantitative analysis of protein S-nitrosation by chemiluminescence in siMock/siMock, siMock/siNFE2L2 and siKEAP1/siNFE2L2 HAECs. n=3, ∗p < 0.05 vs
siMock/siMock, #p < 0.05 vs siMock/siNFE2L2, one-way ANOVA + Bonferroni's.
(E) Analysis of protein S-nitrosation in siMock/siMock, siMock/siNFE2L2 and siKEAP1/siNFE2L2 HAECs. GSNO + cysteine served as a positive control. Cell lysates
were subjected to biotin switch assay, pull downed by streptavidin and separated by SDS-PAGE electrophoresis. Proteins were visualized by silver stain. n = 3. NT –
non-transfected. Representative picture.
(F) Quantitative analysis of PCNA immunoﬂuorescent staining in siMock/siMock, siMock/siNFE2L2 and siKEAP1/siNFE2L2 HAECs. ∗∗∗p < 0.001 vs siMock/siMock,
###p < 0.001 vs siMock/siNFE2L2. n = 3, one-way ANOVA + Bonferroni's.
(G) p21 level in siMock/siMock, siMock/siNFE2L2 and siKEAP1/siNFE2L2 HAECs. Whole-cell lysates were analyzed by immunoblotting. Tubulin served as a loading
control. Representative picture of 3 experiments.
(H) Percentage of cells with increased SA-β-gal activity in siMock/siMock, siMock/siNFE2L2 and siKEAP1/siNFE2L2 HAECs. ∗∗p < 0.01 vs siMock/siMock,
##p < 0.01 vs siMock/siNFE2L2. n = 3, one-way ANOVA + Bonferroni's.
(I–J) Expression of (I) ADH5 and (J) TXNRD1. ∗∗∗p < 0.001 vs siMock/siMock, ##p < 0.01 vs siMock/siNFE2L2. n = 3, one-way ANOVA + Bonferroni's.
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particularly H2O2 and other hydroperoxides, which are the pre-
dominant redox second messengers [56], can be responsible for the
observed weak shift in the redox status of the cell towards more oxi-
dative, but still unharmful, microenvironment. Such conditions may
facilitate the covalent attachment of NO+ to cysteine, which requires
oxidation of ˙NO in the reactions leading to S-nitrosation [57].
For now, we are limited by the general problem of not under-
standing how S-nitrosation occurs, though it is likely that Keap1 is a
SNO synthase. Human Keap1 is a protein possessing 27 cysteines. How
a cysteine of Keap1 diﬀers from the many protein cysteines so that it
can be oxidized by H2O2 under physiological conditions remains to be
elucidated. Modiﬁcation of Keap1 cysteines has been suggested to in-
volve the binding of zinc, which would allow the splitting of the O–O
bond that cannot be achieved by a thiolate alone [58]. The problem
here is that ˙NO must be oxidized to NO+ to react with a thiolate (S−) to
form SNO and Zn2+ cannot achieve that. It is possible that a transition
metal like Fe3+ could bind to a cysteine in Keap1 in place of Zn2+ and
oxidize ˙NO. Or as there was an increase in O2.-, the following could
occur if the Keap1 molecule was close enough to the site of O2.- pro-
duction:
Keap-S- + O2.- - > Keap-S. + O2
Keap-S. + ˙NO - > Keap-SNO
where the presence of a Zn2+ bound to the thiolate would enhance its
nucleophilicity and facilitate a reaction with O2.- to form a thiyl radical.
Increased S-nitrosation is considered as a fateful posttranslational
modiﬁcation due to its detrimental eﬀect on various cellular processes
such as autophagy [42], actin polymerization [59] and protein folding
[60]. It is known that this modiﬁcation may induce the senescent
phenotype [42,59], which is also the case in our experimental models.
In terms of protecting cells, S-nitrosation of caspases was shown to
Fig. 8. Keap1 interacts with GAPDH and NOS in HAECs.
(A) Colocalization between GAPDH (green) and Keap1 (red) in siMock/siMock and siMock/siNFE2L2 HAECs. Representative pictures of 4 experiments. Scale bar
10 μm.
(B) Colocalization between iNOS (red) and Keap1 (green) in siMock/siMock and siMock/siNFE2L2 HAECs. Representative pictures of 3 experiments. Scale bar 10 μm.
(C) Colocalization between phosphorylated (Ser1177) eNOS (green) and Keap1 (red) in siMock/siMock and siMock/siNFE2L2 HAECs. Representative pictures of 3
experiments. Scale bar 10 μm.
(D) Co-immunoprecipitation of Keap1 with phosphorylated (Ser1177) eNOS and GAPDH in siMock/siMock and siMock/siNFE2L2 HAECs. Representative picture of 3
experiments.
(E) Analysis of protein S-nitrosation by biotin switch assay with immunoﬂuorescent detection in siMock/siMock, siMock/siNFE2L2, siNOS2/siNFE2L2, siNOS3/
siNFE2L2, siGAPDH/siNFE2L2 and siKEAP1/siNFE2L2 HAECs. Representative picture of 3 experiments. Scale bar 10 μm
(F) NOX4 level in siMock/siMock, siMock/siNFE2L2 and siKEAP1/siNFE2L2 HAECs. Representative pictures of 3 experiments. Scale bar 10 μm. (For interpretation of
the references to color in this ﬁgure legend, the reader is referred to the Web version of this article.)
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inhibit their enzymatic activity [61]. S-nitrosation may also have a
defensive role as it prevents irreversible protein modiﬁcations similar to
S-glutathionylation [62,63]. As our data show, S-nitrosation of NOX4
has fundamental signiﬁcance in endothelial cells, protecting them from
apoptosis in the absence of Nrf2, the key cellular redox regulator.
Thereby, S-nitrosation determines EC fate, balancing between pre-
mature senescence and cellular death. We found that the protein, which
is directly controlling S-nitrosation in ECs is Keap1, which broadens the
function of Keap1 in the cell beyond the repressor of Nrf2 and redox
sensor. We emphasize that the role of Nrf2/Keap1 system in the anti-
oxidative defense of ECs is a twin-track approach: a regulation of cy-
toprotective genes by Nrf2, but also Keap1-mediated S-nitrosation of
cysteines.
Until recently, the biology of the modiﬁcation of macromolecules by
˙NO and the mechanisms associated with this process were poorly un-
derstood and thought to be non-enzymatic. As described above, this
reaction would require formation of an intermediate NO+ or another
nitrosating agent [64], but the kinetics of such mechanisms raises
constraints in in vivo conditions [20,65]. Here, we propose that Keap1
creates together with NOS and GAPDH an enzymatic complex, similar
to the one found in bacteria [20], which catalyzes the reaction of S-
nitrosation in mammalian cells. Although veriﬁcation of this concept
requires further detailed studies, thought-provoking similarities can be
found between the bacterial system regulating antioxidative response
and S-nitrosation, and mammalian one. The complex of NO synthase
(NarGHI), SNO synthase (Hcp) and transnitrosating protein (GAPDH) is
responsible for protein S-nitrosation in E. coli [20] and this process is
controlled by OxyR [66]. OxyR is the main transcription factor or-
chestrating the genes involved in a defense system in bacteria. It is a
redox-sensitive regulator which is activated by a thiol-disulﬁde switch
model [67]. Thiol groups of OxyR are modiﬁed by oxidation or S-ni-
trosation and turn on the regulons protective from oxidative and ni-
trosative stress, respectively. Hcp, bacterial SNO synthase, is one of the
OxyR target genes and these two may interact [20,66]. Whereas OxyR
is the oxidant sensor in bacteria, the Nrf2-Keap1 axis serves as such in
mammalian cells [68]. Importantly, deletion of OxyR leads to potent
protein S-nitrosation [66], the same eﬀect is found in Nrf2-deﬁcient ECs
(Fig. 5A).
As it was previously demonstrated, S-nitrosation of Keap1 in ECs,
like oxidative modiﬁcation or alkylation, allows Nrf2 activation [69].
Here, we demonstrate that Keap1, with its interaction with NOS and
GAPDH, resembles the bacterial SNO enzymatic complex, and provides
a novel mechanism for NO-based cellular signaling in mammalian cells.
In conclusion, we show that Keap1 governs S-nitrosation in en-
dothelial cells. This serves as an oxidative damage escaping mechanism
relying on NOX4 in ECs, and redirects them from death to senescence.
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